Bovie will buy some Boston Scientific assets

Bovie Medical Corp. announced today an agreement with Natick medical device maker Boston Scientific Corp. to acquire technology and assets for a radio frequency resection device.

A statement issued by Bovie of Melville, N.Y., made no mention of the financial details of the agreement.

The agreement covers Boston Scientific technology, patents, and assets related to the use of conductive sintered steel as an electrode for radio-frequency cutting and coagulation; the hope is that such technology can lower blood loss, quicken the time of many medical procedures, and provide cost savings to hospitals, Bovie said.

Boston Scientific, meanwhile, has been pursuing a long-term plan of divesting itself of nonstrategic assets so that it can focus on such core businesses as making stents, narrow mesh tubes used to prop up arteries that have been unclogged during a medical procedure; an image of one of the company's stents is seen at right.

For recent Globe coverage of Boston Scientific, click here.
(By Chris Reidy, Globe staff)